Sang-jin Daniel Lee - Head of Research & Development at Liminatus Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Head of Research & Development
Issuer Symbol
LIMN, LIMNW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sang-jin Daniel Lee since 05 Feb 2025

There are no transactions reported by Sang-jin Daniel Lee for Liminatus Pharma, Inc.